BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8248056)

  • 1. [Biliary scintigraphy. Application to the study of chronic cholestasis].
    Hecht Y; Kieffel T; Vaubourdolle M; Balladur P; Cogliandolo A; Hannoun L; Nordlinger B; Coutris G; de Saint-Laurent J; Parc R
    Presse Med; 1993 Sep; 22(28):1307-12. PubMed ID: 8248056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholestasis. Recent diagnostic and therapeutic acquisitions].
    Marucci L; Macarri G; Benedetti A
    Recenti Prog Med; 2003 Jan; 94(1):19-24. PubMed ID: 12632996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 7. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
    Parés A; Rodés J
    Gastroenterol Hepatol; 1996 Feb; 19(2):58-67. PubMed ID: 8616682
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
    Lirussi F; Okolicsanyi L
    Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholestasis: therapeutic options].
    Beuers U; Oswald M
    Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of cholestatic liver diseases; the role of ursodeoxycholic acid].
    Stiehl A
    Z Gastroenterol; 1992 Oct; 30(10):743-7. PubMed ID: 1441678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of cholestatic hepatopathies].
    Leuschner U
    Schweiz Rundsch Med Prax; 1992 Aug; 81(34):983-4. PubMed ID: 1529191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis.
    Floreani A; Motta R; Cazzagon N; Franceschet I; Roncalli M; Del Ross T; Rosina F; Lleo A; Mescoli C; Colloredo G; Invernizzi P
    Dig Liver Dis; 2015 May; 47(5):432-5. PubMed ID: 25747115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
    Raedsch R; Stiehl A; Hopf U; Möller B
    Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary sclerosing cholangitis and primary biliary liver cirrhosis as the causes of intrahepatic cholestasis].
    Mandera M; Nowakowska-Duława E; Hartleb M
    Wiad Lek; 1992 May; 45(9-10):366-70. PubMed ID: 1441546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid for the treatment of cholestatic diseases.
    Poupon RE; Poupon R
    Prog Liver Dis; 1992; 10():219-38. PubMed ID: 1296231
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid.
    Güldütuna S; Leuschner U; Imhof M; Zimmer G
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():49-54. PubMed ID: 1449017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning from the pregnane X receptor: how to fight one aggressor with two strategies.
    Rust C; Beuers U
    Liver Int; 2010 Feb; 30(2):161-3. PubMed ID: 20456034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.